[1] Shu HK, Kim MM, Chen P, Furman F, Julin CM, Israel MA.The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression[J]. Proc Natl Acad Sci USA, 1998, 95:14453-14458.
[2] Bocangel DB, Finkelstein S, Schold SC, Bhakat KK, Mitra S, Kokkinakis DM. Multifaceted resistance of gliomas to temozolomide[J]. Clin Cancer Res, 2002, 8:2725-2734.
[3] Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352:987-996.
[4] Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma:a randomized clinical trial[J]. JAMA, 2017, 318:2306-2316.
[5] Ulitsky I, Bartel DP. lincRNAs:genomics, evolution, and mechanisms[J]. Cell, 2013, 154:26-46.
[6] Batista PJ, Chang HY. Long noncoding RNAs:cellular address codes in development and disease[J]. Cell, 2013, 152:1298-1307.
[7] Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs[J]. Cell, 2018, 172:393-407.
[8] Tang Y, Cheung BB, Atmadibrata B, Marshall GM, Dinger ME, Liu PY, Liu T. The regulatory role of long noncoding RNAs in cancer[J]. Cancer Lett, 2017, 391:12-19.
[9] Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function[J]. Genome Biol, 2017, 18:206.
[10] Jiang MC, Ni JJ, Cui WY, Wang BY, Zhuo W. Emerging roles of lncRNA in cancer and therapeutic opportunities[J]. Am J Cancer Res, 2019, 9:1354-1366.
[11] Cohen E, Avrahami D, Frid K, Canello T, Levy Lahad E, Zeligson S, Perlberg S, Chapman J, Cohen OS, Kahana E, Lavon I, Gabizon R. Snord 3A:a molecular marker and modulator of prion disease progression[J]. PLoS One, 2013, 8:E54433.
[12] Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114:97-109.
[13] Mehta S, Lo Cascio C. Developmentally regulated signaling pathways in glioma invasion[J]. Cell Mol Life Sci, 2018, 75:385-402.
[14] Wank M, Schilling D, Schmid TE, Meyer B, Gempt J, Barz M, Schlegel J, Liesche F, Kessel KA, Wiestler B, Bette S, Zimmer C, Combs SE. Human glioma migration and infiltration properties as a target for personalized radiation medicine[J].Cancers (Basel), 2018, 10:E456.
[15] Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of miR-128-3p/GREM1 axis and BMP signaling pathway[J]. Neurotherapeutics, 2018, 15:1139-1157.
[16] Zhou K, Zhang C, Yao H, Zhang X, Zhou Y, Che Y, Huang Y. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132[J]. Mol Cancer, 2018, 17:105.
[17] Ni W, Xia Y, Bi Y, Wen F, Hu D, Luo L. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway[J]. Aging (Albany NY), 2019, 11:1427-1439.
[18] Lin CY, Lovén J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. Transcriptional amplification in tumor cells with elevated c-Myc[J]. Cell, 2012, 151:56-67.
[19] Shindo H, Tani E, Matsumuto T, Hashimoto T, Furuyama J. Stabilization of c-myc protein in human glioma cells[J]. Acta Neuropathol, 1993, 86:345-352.
[20] Liu N, Wang Z, Liu D, Xie P. HOXC13-AS-miR-122-5p-SATB1-C-Myc feedback loop promotes migration, invasion and EMT process in glioma[J]. Onco Targets Ther, 2019, 12:7165-7173. |